Loading…

Procalcitonin as a marker of respiratory disorder in neonates

Background Serum procalcitonin (PCT) increases in various respiratory disorders such as acute respiratory distress syndrome. Elevated PCT is also observed in healthy neonates. In this study, we investigated whether PCT is a good marker of respiratory disorder in neonates. Methods A total of 155 neon...

Full description

Saved in:
Bibliographic Details
Published in:Pediatrics international 2015-04, Vol.57 (2), p.263-268
Main Authors: Ochi, Fumihiro, Higaki, Takashi, Ohta, Masaaki, Yamauchi, Toshifumi, Tezuka, Mari, Chisaka, Toshiyuki, Moritani, Tomozo, Tauchi, Hisamichi, Ishii, Eiichi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4815-7cb2613f941c756ce1c2d203f508900d2c5e5dae6cc840de384da1b16baeb91e3
cites cdi_FETCH-LOGICAL-c4815-7cb2613f941c756ce1c2d203f508900d2c5e5dae6cc840de384da1b16baeb91e3
container_end_page 268
container_issue 2
container_start_page 263
container_title Pediatrics international
container_volume 57
creator Ochi, Fumihiro
Higaki, Takashi
Ohta, Masaaki
Yamauchi, Toshifumi
Tezuka, Mari
Chisaka, Toshiyuki
Moritani, Tomozo
Tauchi, Hisamichi
Ishii, Eiichi
description Background Serum procalcitonin (PCT) increases in various respiratory disorders such as acute respiratory distress syndrome. Elevated PCT is also observed in healthy neonates. In this study, we investigated whether PCT is a good marker of respiratory disorder in neonates. Methods A total of 155 neonates with or without respiratory disorder, were eligible for the study. PCT was measured on electrochemiluminescence immunoassay. Each neonate was allocated to the non‐respiratory disorder (control) group (n = 95), or a respiratory disorder group (n = 60). PCT was compared between the groups, and association with other markers, including C‐reactive protein (CRP) and white blood cell (WBC) count, was analyzed. Results Of the 60 neonates in the respiratory disorder group, 39, 10, five, one, two, two, and one neonates had transient tachypnea of the newborn, respiratory distress syndrome, air leak syndrome, meconium aspiration syndrome, 18‐trisomy, neonatal asphyxia, and congenital diaphragmatic hernia, respectively. Mean PCT, CRP and WBC count in the respiratory disorder group were 9.01 ng/mL, 0.26 mg/dL, and 16 100 cells/μL, respectively. The area under the curve obtained for PCT in distinguishing between the respiratory disorder and control groups was 0.85 (sensitivity, 66.7%; specificity, 93.0%; optimum cut‐off, 3.73 ng/mL), that for CRP was 0.72 (sensitivity, 75.0%; specificity, 64.6%; optimum cut‐off, 0.14 mg/dL), and for WBC it was 0.44 (sensitivity, 60.0%; specificity, 29.6%; optimum cut‐off, 15 000 cells/μL). Conclusions PCT is more susceptible, as a diagnostic parameter of infection, to the effect of respiratory disturbance than CRP and WBC.
doi_str_mv 10.1111/ped.12505
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1673371758</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1673371758</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4815-7cb2613f941c756ce1c2d203f508900d2c5e5dae6cc840de384da1b16baeb91e3</originalsourceid><addsrcrecordid>eNp1kE1LAzEQhoMoVqsH_4AseNHDtvnYbNKDB6m1lRYtqOgtZLOzsHW7qckW7b83ta0HwblkGJ55mTwInRHcIaG6C8g7hHLM99ARSRIaU4zf9kPPqIwlTkULHXs_wxhLIZND1KKcUsZScYSup84aXZmysXVZR9pHOppr9w4uskXkwC9KpxvrVlFeeuvyMA9YDbbWDfgTdFDoysPp9m2jl7vBc38UTx6H9_2bSWwSSXgsTEZTwopeQozgqQFiaE4xKziWPYxzajjwXENqjExwDkwmuSYZSTMNWY8Aa6PLTe7C2Y8l-EbNS2-gqnS4ZOkVSQVjggguA3rxB53ZpavDdWuKikAlvUBdbSjjrPcOCrVwZfj3ShGs1k5VcKp-nAb2fJu4zOZhuiN3EgPQ3QCfZQWr_5PUdHC7i4w3G6Vv4Ot3I3hXIU9w9fowVP0xTcdPbKSm7BsH444s</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1672771749</pqid></control><display><type>article</type><title>Procalcitonin as a marker of respiratory disorder in neonates</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Ochi, Fumihiro ; Higaki, Takashi ; Ohta, Masaaki ; Yamauchi, Toshifumi ; Tezuka, Mari ; Chisaka, Toshiyuki ; Moritani, Tomozo ; Tauchi, Hisamichi ; Ishii, Eiichi</creator><creatorcontrib>Ochi, Fumihiro ; Higaki, Takashi ; Ohta, Masaaki ; Yamauchi, Toshifumi ; Tezuka, Mari ; Chisaka, Toshiyuki ; Moritani, Tomozo ; Tauchi, Hisamichi ; Ishii, Eiichi</creatorcontrib><description>Background Serum procalcitonin (PCT) increases in various respiratory disorders such as acute respiratory distress syndrome. Elevated PCT is also observed in healthy neonates. In this study, we investigated whether PCT is a good marker of respiratory disorder in neonates. Methods A total of 155 neonates with or without respiratory disorder, were eligible for the study. PCT was measured on electrochemiluminescence immunoassay. Each neonate was allocated to the non‐respiratory disorder (control) group (n = 95), or a respiratory disorder group (n = 60). PCT was compared between the groups, and association with other markers, including C‐reactive protein (CRP) and white blood cell (WBC) count, was analyzed. Results Of the 60 neonates in the respiratory disorder group, 39, 10, five, one, two, two, and one neonates had transient tachypnea of the newborn, respiratory distress syndrome, air leak syndrome, meconium aspiration syndrome, 18‐trisomy, neonatal asphyxia, and congenital diaphragmatic hernia, respectively. Mean PCT, CRP and WBC count in the respiratory disorder group were 9.01 ng/mL, 0.26 mg/dL, and 16 100 cells/μL, respectively. The area under the curve obtained for PCT in distinguishing between the respiratory disorder and control groups was 0.85 (sensitivity, 66.7%; specificity, 93.0%; optimum cut‐off, 3.73 ng/mL), that for CRP was 0.72 (sensitivity, 75.0%; specificity, 64.6%; optimum cut‐off, 0.14 mg/dL), and for WBC it was 0.44 (sensitivity, 60.0%; specificity, 29.6%; optimum cut‐off, 15 000 cells/μL). Conclusions PCT is more susceptible, as a diagnostic parameter of infection, to the effect of respiratory disturbance than CRP and WBC.</description><identifier>ISSN: 1328-8067</identifier><identifier>EISSN: 1442-200X</identifier><identifier>DOI: 10.1111/ped.12505</identifier><identifier>PMID: 25223367</identifier><language>eng</language><publisher>Australia: Blackwell Publishing Ltd</publisher><subject>Biomarkers ; Biomarkers - blood ; C-reactive protein ; C-Reactive Protein - metabolism ; Calcitonin - blood ; Female ; Humans ; Infant, Newborn ; Leukocyte Count ; Luminescent Measurements ; Male ; neonate ; Pediatrics ; procalcitonin electrochemiluminescence immunoassay ; Respiration Disorders - diagnosis ; Respiratory diseases ; ROC Curve ; Sensitivity and Specificity ; white blood cell count</subject><ispartof>Pediatrics international, 2015-04, Vol.57 (2), p.263-268</ispartof><rights>2014 Japan Pediatric Society</rights><rights>2014 Japan Pediatric Society.</rights><rights>Pediatrics International © 2015 Japan Pediatric Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4815-7cb2613f941c756ce1c2d203f508900d2c5e5dae6cc840de384da1b16baeb91e3</citedby><cites>FETCH-LOGICAL-c4815-7cb2613f941c756ce1c2d203f508900d2c5e5dae6cc840de384da1b16baeb91e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25223367$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ochi, Fumihiro</creatorcontrib><creatorcontrib>Higaki, Takashi</creatorcontrib><creatorcontrib>Ohta, Masaaki</creatorcontrib><creatorcontrib>Yamauchi, Toshifumi</creatorcontrib><creatorcontrib>Tezuka, Mari</creatorcontrib><creatorcontrib>Chisaka, Toshiyuki</creatorcontrib><creatorcontrib>Moritani, Tomozo</creatorcontrib><creatorcontrib>Tauchi, Hisamichi</creatorcontrib><creatorcontrib>Ishii, Eiichi</creatorcontrib><title>Procalcitonin as a marker of respiratory disorder in neonates</title><title>Pediatrics international</title><addtitle>Pediatr Int</addtitle><description>Background Serum procalcitonin (PCT) increases in various respiratory disorders such as acute respiratory distress syndrome. Elevated PCT is also observed in healthy neonates. In this study, we investigated whether PCT is a good marker of respiratory disorder in neonates. Methods A total of 155 neonates with or without respiratory disorder, were eligible for the study. PCT was measured on electrochemiluminescence immunoassay. Each neonate was allocated to the non‐respiratory disorder (control) group (n = 95), or a respiratory disorder group (n = 60). PCT was compared between the groups, and association with other markers, including C‐reactive protein (CRP) and white blood cell (WBC) count, was analyzed. Results Of the 60 neonates in the respiratory disorder group, 39, 10, five, one, two, two, and one neonates had transient tachypnea of the newborn, respiratory distress syndrome, air leak syndrome, meconium aspiration syndrome, 18‐trisomy, neonatal asphyxia, and congenital diaphragmatic hernia, respectively. Mean PCT, CRP and WBC count in the respiratory disorder group were 9.01 ng/mL, 0.26 mg/dL, and 16 100 cells/μL, respectively. The area under the curve obtained for PCT in distinguishing between the respiratory disorder and control groups was 0.85 (sensitivity, 66.7%; specificity, 93.0%; optimum cut‐off, 3.73 ng/mL), that for CRP was 0.72 (sensitivity, 75.0%; specificity, 64.6%; optimum cut‐off, 0.14 mg/dL), and for WBC it was 0.44 (sensitivity, 60.0%; specificity, 29.6%; optimum cut‐off, 15 000 cells/μL). Conclusions PCT is more susceptible, as a diagnostic parameter of infection, to the effect of respiratory disturbance than CRP and WBC.</description><subject>Biomarkers</subject><subject>Biomarkers - blood</subject><subject>C-reactive protein</subject><subject>C-Reactive Protein - metabolism</subject><subject>Calcitonin - blood</subject><subject>Female</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Leukocyte Count</subject><subject>Luminescent Measurements</subject><subject>Male</subject><subject>neonate</subject><subject>Pediatrics</subject><subject>procalcitonin electrochemiluminescence immunoassay</subject><subject>Respiration Disorders - diagnosis</subject><subject>Respiratory diseases</subject><subject>ROC Curve</subject><subject>Sensitivity and Specificity</subject><subject>white blood cell count</subject><issn>1328-8067</issn><issn>1442-200X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNp1kE1LAzEQhoMoVqsH_4AseNHDtvnYbNKDB6m1lRYtqOgtZLOzsHW7qckW7b83ta0HwblkGJ55mTwInRHcIaG6C8g7hHLM99ARSRIaU4zf9kPPqIwlTkULHXs_wxhLIZND1KKcUsZScYSup84aXZmysXVZR9pHOppr9w4uskXkwC9KpxvrVlFeeuvyMA9YDbbWDfgTdFDoysPp9m2jl7vBc38UTx6H9_2bSWwSSXgsTEZTwopeQozgqQFiaE4xKziWPYxzajjwXENqjExwDkwmuSYZSTMNWY8Aa6PLTe7C2Y8l-EbNS2-gqnS4ZOkVSQVjggguA3rxB53ZpavDdWuKikAlvUBdbSjjrPcOCrVwZfj3ShGs1k5VcKp-nAb2fJu4zOZhuiN3EgPQ3QCfZQWr_5PUdHC7i4w3G6Vv4Ot3I3hXIU9w9fowVP0xTcdPbKSm7BsH444s</recordid><startdate>201504</startdate><enddate>201504</enddate><creator>Ochi, Fumihiro</creator><creator>Higaki, Takashi</creator><creator>Ohta, Masaaki</creator><creator>Yamauchi, Toshifumi</creator><creator>Tezuka, Mari</creator><creator>Chisaka, Toshiyuki</creator><creator>Moritani, Tomozo</creator><creator>Tauchi, Hisamichi</creator><creator>Ishii, Eiichi</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201504</creationdate><title>Procalcitonin as a marker of respiratory disorder in neonates</title><author>Ochi, Fumihiro ; Higaki, Takashi ; Ohta, Masaaki ; Yamauchi, Toshifumi ; Tezuka, Mari ; Chisaka, Toshiyuki ; Moritani, Tomozo ; Tauchi, Hisamichi ; Ishii, Eiichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4815-7cb2613f941c756ce1c2d203f508900d2c5e5dae6cc840de384da1b16baeb91e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Biomarkers</topic><topic>Biomarkers - blood</topic><topic>C-reactive protein</topic><topic>C-Reactive Protein - metabolism</topic><topic>Calcitonin - blood</topic><topic>Female</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Leukocyte Count</topic><topic>Luminescent Measurements</topic><topic>Male</topic><topic>neonate</topic><topic>Pediatrics</topic><topic>procalcitonin electrochemiluminescence immunoassay</topic><topic>Respiration Disorders - diagnosis</topic><topic>Respiratory diseases</topic><topic>ROC Curve</topic><topic>Sensitivity and Specificity</topic><topic>white blood cell count</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ochi, Fumihiro</creatorcontrib><creatorcontrib>Higaki, Takashi</creatorcontrib><creatorcontrib>Ohta, Masaaki</creatorcontrib><creatorcontrib>Yamauchi, Toshifumi</creatorcontrib><creatorcontrib>Tezuka, Mari</creatorcontrib><creatorcontrib>Chisaka, Toshiyuki</creatorcontrib><creatorcontrib>Moritani, Tomozo</creatorcontrib><creatorcontrib>Tauchi, Hisamichi</creatorcontrib><creatorcontrib>Ishii, Eiichi</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatrics international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ochi, Fumihiro</au><au>Higaki, Takashi</au><au>Ohta, Masaaki</au><au>Yamauchi, Toshifumi</au><au>Tezuka, Mari</au><au>Chisaka, Toshiyuki</au><au>Moritani, Tomozo</au><au>Tauchi, Hisamichi</au><au>Ishii, Eiichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Procalcitonin as a marker of respiratory disorder in neonates</atitle><jtitle>Pediatrics international</jtitle><addtitle>Pediatr Int</addtitle><date>2015-04</date><risdate>2015</risdate><volume>57</volume><issue>2</issue><spage>263</spage><epage>268</epage><pages>263-268</pages><issn>1328-8067</issn><eissn>1442-200X</eissn><abstract>Background Serum procalcitonin (PCT) increases in various respiratory disorders such as acute respiratory distress syndrome. Elevated PCT is also observed in healthy neonates. In this study, we investigated whether PCT is a good marker of respiratory disorder in neonates. Methods A total of 155 neonates with or without respiratory disorder, were eligible for the study. PCT was measured on electrochemiluminescence immunoassay. Each neonate was allocated to the non‐respiratory disorder (control) group (n = 95), or a respiratory disorder group (n = 60). PCT was compared between the groups, and association with other markers, including C‐reactive protein (CRP) and white blood cell (WBC) count, was analyzed. Results Of the 60 neonates in the respiratory disorder group, 39, 10, five, one, two, two, and one neonates had transient tachypnea of the newborn, respiratory distress syndrome, air leak syndrome, meconium aspiration syndrome, 18‐trisomy, neonatal asphyxia, and congenital diaphragmatic hernia, respectively. Mean PCT, CRP and WBC count in the respiratory disorder group were 9.01 ng/mL, 0.26 mg/dL, and 16 100 cells/μL, respectively. The area under the curve obtained for PCT in distinguishing between the respiratory disorder and control groups was 0.85 (sensitivity, 66.7%; specificity, 93.0%; optimum cut‐off, 3.73 ng/mL), that for CRP was 0.72 (sensitivity, 75.0%; specificity, 64.6%; optimum cut‐off, 0.14 mg/dL), and for WBC it was 0.44 (sensitivity, 60.0%; specificity, 29.6%; optimum cut‐off, 15 000 cells/μL). Conclusions PCT is more susceptible, as a diagnostic parameter of infection, to the effect of respiratory disturbance than CRP and WBC.</abstract><cop>Australia</cop><pub>Blackwell Publishing Ltd</pub><pmid>25223367</pmid><doi>10.1111/ped.12505</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1328-8067
ispartof Pediatrics international, 2015-04, Vol.57 (2), p.263-268
issn 1328-8067
1442-200X
language eng
recordid cdi_proquest_miscellaneous_1673371758
source Wiley-Blackwell Read & Publish Collection
subjects Biomarkers
Biomarkers - blood
C-reactive protein
C-Reactive Protein - metabolism
Calcitonin - blood
Female
Humans
Infant, Newborn
Leukocyte Count
Luminescent Measurements
Male
neonate
Pediatrics
procalcitonin electrochemiluminescence immunoassay
Respiration Disorders - diagnosis
Respiratory diseases
ROC Curve
Sensitivity and Specificity
white blood cell count
title Procalcitonin as a marker of respiratory disorder in neonates
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T21%3A34%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Procalcitonin%20as%20a%20marker%20of%20respiratory%20disorder%20in%20neonates&rft.jtitle=Pediatrics%20international&rft.au=Ochi,%20Fumihiro&rft.date=2015-04&rft.volume=57&rft.issue=2&rft.spage=263&rft.epage=268&rft.pages=263-268&rft.issn=1328-8067&rft.eissn=1442-200X&rft_id=info:doi/10.1111/ped.12505&rft_dat=%3Cproquest_cross%3E1673371758%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4815-7cb2613f941c756ce1c2d203f508900d2c5e5dae6cc840de384da1b16baeb91e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1672771749&rft_id=info:pmid/25223367&rfr_iscdi=true